Roivant Sciences Ltd. Cash Flow Statement

Cash Flow Statement Mar2021 Mar2022 Dec2022 Mar2023 Dec2023 Mar2024 Dec2024 Mar2025
Operating Activities
Net Income -900.23M-924.12M-226.39M-315.15M373.19M
Share-based Compensation 84.96M564.96M217.78M199.63M289.03M
Gains from Sales and Divestitures 5.76M11.98M5.50M6.84M4.94M6.09M
Gains from Investment Securities -16.98M443.75M21.21M-16.49M61.91M
Non-cash Items 1.90M55.63M64.92M91.67M97.16M107.48M110.69M
Cash from Operations -552.14M-677.73M-843.39M-765.27M-839.45M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 7.27M7.57M6.84M69.96M
Depreciation & Amortization (CF) 5.93M18.86M22.04M14.07M
Change in Working Capital
Change in Account Payables 3.75M15.40M4.36M22.68M-18.17M
Change in Accured Expenses 9.22M50.59M38.96M40.15M-10.07M
Investing Activities
Capital Expenditures 5.81M17.44M12.69M1.38M4.60M
Sales of Property, Plant and Equipment 5233.40M110.39M
Divestments 47.50M260.59M
Change in Acquisitions & Divestments 320.17M1960.00M
Cash from Investing Activities -31.70M303.30M-44.27M5203.62M-1766.29M
Financing Activities
Other financing activities -1.56M
Debt Issuance and Repayment
Short-Term Debt issuances 36.40M159.90M
Change in Capital Stock
Shares Issued 0.41M311.98M199.82M49.60M
Shares Repurchased 1293.23M
Misc.
Cash from Financing Activities 456.26M306.79M499.46M419.36M-1219.79M
Exchange Rate Effect 6.28M0.62M0.75M
Change in Cash -127.58M-67.64M-381.92M4858.34M-3824.79M
Free Cash Flow -557.94M-695.16M-856.08M-766.65M-844.05M
Net Cash Flow -127.58M-67.64M-388.20M4857.72M-3825.54M